644 related articles for article (PubMed ID: 26600435)
1. Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?
Mahmud SM; Bozat-Emre S; Hammond G; Elliott L; Van Caeseele P
PLoS One; 2015; 10(11):e0142754. PubMed ID: 26600435
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
[TBL] [Abstract][Full Text] [Related]
3. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
[TBL] [Abstract][Full Text] [Related]
4. No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.
Mahmud SM; Van Caeseele P; Hammond G; Kurbis C; Hilderman T; Elliott L
Emerg Infect Dis; 2012 May; 18(5):801-10. PubMed ID: 22516189
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.
Ortqvist A; Bennet R; Rinder MR; Lindblad H; Eriksson M
Vaccine; 2012 Aug; 30(39):5699-702. PubMed ID: 22819987
[TBL] [Abstract][Full Text] [Related]
6. Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study.
Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Hum Vaccin Immunother; 2015; 11(5):1088-93. PubMed ID: 25901995
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years.
Hadler JL; Baker TN; Papadouka V; France AM; Zimmerman C; Livingston KA; Zucker JR
J Infect Dis; 2012 Jul; 206(1):49-55. PubMed ID: 22551808
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination.
Gefenaite G; Tacken M; Bos J; Stirbu-Wagner I; Korevaar JC; Stolk RP; Wolters B; Bijl M; Postma MJ; Wilschut J; Nichol KL; Hak E
PLoS One; 2013; 8(6):e66125. PubMed ID: 23840413
[TBL] [Abstract][Full Text] [Related]
11. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
[TBL] [Abstract][Full Text] [Related]
12. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.
Gilca R; Deceuninck G; De Serres G; Boulianne N; Sauvageau C; Quach C; Boucher FD; Skowronski DM
Pediatrics; 2011 Nov; 128(5):e1084-91. PubMed ID: 21987710
[TBL] [Abstract][Full Text] [Related]
14. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
[TBL] [Abstract][Full Text] [Related]
15. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.
Yin JK; Chow MY; Khandaker G; King C; Richmond P; Heron L; Booy R
Vaccine; 2012 May; 30(21):3209-22. PubMed ID: 22387221
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
[TBL] [Abstract][Full Text] [Related]
17. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
[TBL] [Abstract][Full Text] [Related]
19. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).
Blyth CC; Macartney KK; Hewagama S; Senenayake S; Friedman ND; Simpson G; Upham J; Kotsimbos T; Kelly P; Cheng AC
Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494798
[TBL] [Abstract][Full Text] [Related]
20. Possible Impact of Yearly Childhood Vaccination With Trivalent Inactivated Influenza Vaccine (TIV) on the Immune Response to the Pandemic Strain H1N1.
Amer A; Fischer H; Li X; Asmar B
Clin Pediatr (Phila); 2016 Mar; 55(3):245-50. PubMed ID: 26159622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
